Expression and purification of amyloid-β peptides from Escherichia coli

Protein Expression and Purification

Volumn 66, Issue 1, 2009, Pages 107-112

  Garai, Kanchan ^a   Crick, Scott L ^a   Mustafi, Sourajit M ^a   Frieden, Carl ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid ; Expression; Fatty acid binding protein; Fusion protein

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); FATTY ACID BINDING PROTEIN; HYBRID PROTEIN; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ARTICLE; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ESCHERICHIA COLI; FATTY ACID-BINDING PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS;

ESCHERICHIA COLI;

EID: 63649096009     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2009.02.009     Document Type: Article

References (27)

1. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
2. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
3. Teplow D.B. Structural and kinetic features of amyloid beta-protein fibrillogenesis. Amyloid 5 (1998) 121-142
4. Lorenzo A., and Yankner B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. Proc. Natl. Acad. Sci. USA 91 (1994) 12243-12247
5. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Mondron M.M., Lomakin A., Benedek G.B., Selkoe D.J., and Teplow D.B. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274 (1999) 25945-25952
6. Klein W.L., Krafft G.A., and Finch C.E. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum. Trends Neurosci. 24 (2001) 219-224
7. Lashuel H.A., Hartley D., Petre B.M., Walz T., and Lansbury Jr. P.T. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418 (2002) 291
8. Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N., and Sato K. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc. Natl. Acad. Sci. USA 100 (2003) 6370-6375
9. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., and Selkoe D.J. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19 (1999) 8876-8884
10. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8 (2005) 79-84
11. Holtzman D.M. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J. Mol. Neurosci. 23 (2004) 247-254
12. Sharpe S., Yau W.M., and Tycko R. Expression and purification of a recombinant peptide from the Alzheimer's beta-amyloid protein for solid-state NMR. Protein Expr. Purif. 42 (2005) 200-210
13. LaVallie E.R., DiBlasio E.A., Kovacic S., Grant K.L., Schendel P.F., and McCoy J.M. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (N.Y.) 11 (1993) 187-193
14. Morrow J.A., Arnold K.S., and Weisgraber K.H. Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli. Protein Expr. Purif. 16 (1999) 224-230
15. Austin B.P., Nallamsetty S., and Waugh D.S. Hexahistidine-tagged maltose-binding protein as a fusion partner for the production of soluble recombinant proteins in Escherichia coli. Methods Mol. Biol. 498 (2009) 157-172
16. Dobeli H., Draeger N., Huber G., Jakob P., Schmidt D., Seilheimer B., Stuber D., Wipf B., and Zulauf M. A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide. Biotechnology (N.Y.) 13 (1995) 988-993
17. Hortschansky P., Schroeckh V., Christopeit T., Zandomeneghi G., and Fandrich M. The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Prot. Sci. 14 (2005) 1753-1759
18. Lee E.K., Hwang J.H., Shin D.Y., Kim D.I., and Yoo Y.J. Production of recombinant amyloid-beta peptide 42 as an ubiquitin extension. Protein Expr. Purif. 40 (2005) 183-189
19. Nagata-Uchiyama M., Yaguchi M., Hirano Y., and Ueda T. Expression and purification of uniformly (15)N-labeled amyloid beta peptide 1-40 in Escherichia coli. Protein Pept. Lett. 14 (2007) 788-792
20. Zhang L., Yu H., Song C., Lin X., Chen B., Tan C., Cao G., and Wang Z. Expression, purification, and characterization of recombinant human beta-amyloid42 peptide in Escherichia coli. Protein Expr. Purif. 64 (2009) 55-62
21. Sacchettini J.C., Banaszak L.J., and Gordon J.I. Expression of rat intestinal fatty acid binding protein in E. coli and its subsequent structural analysis: a model system for studying the molecular details of fatty acid-protein interaction. Mol. Cell. Biochem. 98 (1990) 81-93
22. 15N assignments and chemical shift-derived secondary structure of intestinal fatty acid-binding protein. J. Biomol. NMR 6 (1995) 198-210
23. Jiang N., and Frieden C. Intestinal fatty acid binding protein: characterization of mutant proteins containing inserted cysteine residues. Biochemistry 32 (1993) 11015-11021
24. Kim K., and Frieden C. Turn scanning by site-directed mutagenesis: application to the protein folding problem using the intestinal fatty acid binding protein. Prot. Sci. 7 (1998) 1821-1828
25. Chattopadhyay K., Zhong S., Yeh S.R., Rousseau D.L., and Frieden C. The intestinal fatty acid binding protein: the role of turns in fast and slow folding processes. Biochemistry 41 (2002) 4040-4047
26. 19F-labeled proteins for NMR studies. Methods Enzymol. 380 (2004) 400-415
27. Macao B., Hoyer W., Sandberg A., Brorsson A.C., Dobson C.M., and Hard T. Recombinant amyloid beta-peptide production by coexpression with an antibody ligand BMC. Biotechnology 8 (2008) 82